MOBILion takes in $60m Series C

MOBILion Systems Inc, a provider of instrumentation for biomarker discovery, diagnostics and biotherapeutic drug characterization, has raised $60 million in Series C financing.

MOBILion Systems Inc, a provider of instrumentation for biomarker discovery, diagnostics and biotherapeutic drug characterization, has raised $60 million in Series C financing. D1 Capital Partners led the round.

Source: Press Release